QC
KRRO icon

Quadrature Capital’s Korro Bio KRRO Stock Holding History

Quadrature Capital’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,356
Closed -$230K – 1845
2026
Q1 		$230K Sell
20,356
-6,708
-25% -$73.8K ﹤0.01% 1069
2025
Q4 		$217K Buy
+27,064
New +$633K ﹤0.01% 952

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Quadrature Capital's KRRO Position: Q2 2026 in Review

Quadrature Capital sold out of Korro Bio (KRRO) in Q2 2026, closing a stake of 20,356 shares — an estimated $230K sold.

Quadrature Capital first reported a position in KRRO in Q4 2025 and held it in 2 quarters. The position peaked at $230K in Q1 2026. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Quadrature Capital reported no remaining Korro Bio position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 20,356 Korro Bio shares in Q2 2026, an estimated $230K.
  • Quadrature Capital first reported a position in Korro Bio in Q4 2025 and held it in 2 quarters.
  • Quadrature Capital's Korro Bio position peaked at $230K in Q1 2026.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.